Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

615 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Comparison of idraparinux with vitamin K antagonists for prevention of thromboembolism in patients with atrial fibrillation: a randomised, open-label, non-inferiority trial.
Amadeus Investigators; Bousser MG, Bouthier J, Büller HR, Cohen AT, Crijns H, Davidson BL, Halperin J, Hankey G, Levy S, Pengo V, Prandoni P, Prins MH, Tomkowski W, Torp-Pedersen C, Wyse DG. Amadeus Investigators, et al. Among authors: prandoni p. Lancet. 2008 Jan 26;371(9609):315-21. doi: 10.1016/S0140-6736(08)60168-3. Lancet. 2008. PMID: 18294998 Clinical Trial.
Deep-vein thrombosis.
Lensing AW, Prandoni P, Prins MH, Büller HR. Lensing AW, et al. Among authors: prandoni p. Lancet. 1999 Feb 6;353(9151):479-85. doi: 10.1016/s0140-6736(98)04298-6. Lancet. 1999. PMID: 9989735 Review.
Travel and risk of venous thrombosis.
Kraaijenhagen RA, Haverkamp D, Koopman MM, Prandoni P, Piovella F, Büller HR. Kraaijenhagen RA, et al. Among authors: prandoni p. Lancet. 2000 Oct 28;356(9240):1492-3. doi: 10.1016/S0140-6736(00)02878-6. Lancet. 2000. PMID: 11081538
Treatment of venous thrombosis with intravenous unfractionated heparin administered in the hospital as compared with subcutaneous low-molecular-weight heparin administered at home. The Tasman Study Group.
Koopman MM, Prandoni P, Piovella F, Ockelford PA, Brandjes DP, van der Meer J, Gallus AS, Simonneau G, Chesterman CH, Prins MH. Koopman MM, et al. Among authors: prandoni p. N Engl J Med. 1996 Mar 14;334(11):682-7. doi: 10.1056/NEJM199603143341102. N Engl J Med. 1996. PMID: 8594426 Free article. Clinical Trial.
Venous thromboembolism and the risk of subsequent symptomatic atherosclerosis.
Prandoni P, Ghirarduzzi A, Prins MH, Pengo V, Davidson BL, Sørensen H, Pesavento R, Iotti M, Casiglia E, Iliceto S, Pagnan A, Lensing AW. Prandoni P, et al. J Thromb Haemost. 2006 Sep;4(9):1891-6. doi: 10.1111/j.1538-7836.2006.02058.x. J Thromb Haemost. 2006. PMID: 16961597 Free article.
International clinical practice guidelines for the treatment and prophylaxis of venous thromboembolism in patients with cancer.
Farge D, Debourdeau P, Beckers M, Baglin C, Bauersachs RM, Brenner B, Brilhante D, Falanga A, Gerotzafias GT, Haim N, Kakkar AK, Khorana AA, Lecumberri R, Mandala M, Marty M, Monreal M, Mousa SA, Noble S, Pabinger I, Prandoni P, Prins MH, Qari MH, Streiff MB, Syrigos K, Bounameaux H, Büller HR. Farge D, et al. Among authors: prandoni p. J Thromb Haemost. 2013 Jan;11(1):56-70. doi: 10.1111/jth.12070. J Thromb Haemost. 2013. PMID: 23217107 Free article. Review.
615 results